Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: dosage and field strength.

Abstract

Our results confirm that 0.1 mmol/kg gadopentetate dimeglumine is more effective at enhancing intracranial tumors than lower doses at mid and high field MR units.